Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Gyre Therapeutics (GYRE) Return on Assets (2016 - 2025)

Historic Return on Assets for Gyre Therapeutics (GYRE) over the last 17 years, with Q3 2025 value amounting to 0.07%.

  • Gyre Therapeutics' Return on Assets rose 7600.0% to 0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07%, marking a year-over-year increase of 7600.0%. This contributed to the annual value of 0.14% for FY2024, which is 10000.0% up from last year.
  • According to the latest figures from Q3 2025, Gyre Therapeutics' Return on Assets is 0.07%, which was up 7600.0% from 0.05% recorded in Q2 2025.
  • Gyre Therapeutics' 5-year Return on Assets high stood at 0.43% for Q1 2023, and its period low was 1.67% during Q1 2022.
  • Over the past 5 years, Gyre Therapeutics' median Return on Assets value was 0.68% (recorded in 2024), while the average stood at 0.56%.
  • Examining YoY changes over the last 5 years, Gyre Therapeutics' Return on Assets showed a top increase of 21000bps in 2023 and a maximum decrease of -15100bps in 2023.
  • Gyre Therapeutics' Return on Assets (Quarter) stood at 1.31% in 2021, then surged by 105bps to 0.06% in 2022, then tumbled by -2407bps to 1.36% in 2023, then surged by 110bps to 0.13% in 2024, then tumbled by -49bps to 0.07% in 2025.
  • Its Return on Assets stands at 0.07% for Q3 2025, versus 0.05% for Q2 2025 and 0.08% for Q1 2025.